Company profile
UK company 06475379, incorporated on 16 January 2008.
Abingdon Health | Lateral Flow Test Manufacture and Development
Assay development and high-volume lateral flow test contract manufacturing. Helping you move faster, contain risks and embrace opportunities
Company number 06475379
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
SH01 | Transaction MzUzOTczNDg5N2FkaXF6a2N4
Published 19 Aug 2026 12:52
Company registered at Companies House
1 Jan 2019 to 31 Dec 2020
"Lateral flow assays (LFA) are diagnostics tests where a liquid sample is applied to a small nitrocellulose membrane pre-patterned with reagents for detection of particular proteins, cells, chemical molecules or microorganisms. The existing market is worth circa $5.5bn per annum (Source: MarketsandMarkets 2017 Lateral Flow Assay Market Report) with LFAs u...
1 Jun 2018 to 28 Feb 2021
"As the world population continues to grow, we need to produce more food for more people, without compromising on animal welfare. Disease control in animals plays a major role in achieving this. Disease is estimated to reduce productivity in the livestock industry by 20% per annum, with losses from mortality, treatment costs, increased labour and reduced ...
